explore
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Changes to biosimilar regulatory framework must prioritize patients
Next article: Changes to biosimilar regulatory framework must prioritize patients
focus
hotspot
-
Illumina slashes 2023 revenue projections yet again
2025-09-29 17:18 -
CDC advisers recommend seasonal use of Pfizer RSV shot
2025-09-29 17:15 -
Readout LOUD podcast: possible new ALS drug, artificial wombs
2025-09-29 17:05 -
STAT Virtual Event: Putting AI to the Test
2025-09-29 17:01 -
FDA panel to weigh approval of NurOwn, controversial ALS drug
2025-09-29 16:47 -
STAT Virtual Event: Putting AI to the Test
2025-09-29 16:17